Teleradiology companies in 2026: categories and criteria

Type "teleradiology companies" into a search engine and you get a dozen top-ten lists, most of them written by the companies that appear in them. This page does something different: it maps the companies by category, then hands you the evaluation framework a ranking pretends to replace, because which company belongs at the top depends on your study mix, your volume shape, and the failure you are hiring your way out of.

Disclosure first, since this publisher belongs on the map it is drawing: AstraRad is one of the subspecialty final-read practices described below, 240 fellowship-trained radiologists across ten subspecialties, per-report billing with no minimums, and the published numbers cited through this piece as one worked example. The framework itself is vendor-neutral, and it will happily score us against anyone; a written rate card for running that comparison arrives within one business day of a request.

The teleradiology companies, sorted by category

The named companies below are the ones that recur on US shortlists, with what each publishes about itself as of this writing. The categories, and the deeper fit analysis behind them, are covered in the provider types article; this is the company-level view.

Category	Companies most often shortlisted	The category's defining trait
National overnight networks	vRad (part of Radiology Partners since 2020)	Scale: vRad publishes 500+ radiologists and 7.2 million annual studies
Large independents	ONRAD (acquired Direct Radiology, January 2025)	Reading plus hospital radiology management in one contract
Radiologist-founded platform practices	StatRad (acquired by I-MED Radiology, July 2024)	In-house platform control; performance disclosed privately
Published-price outliers	NDX Imaging	A public rate table, from $12 per X-ray, checked September 2026
Subspecialty final-read practices	AstraRad and a small set of peers	Routing by modality and body part to fellowship-trained readers, finals only
Mid-size independents	Dozens: Vesta, USARad, Teleradiology Solutions, and others	The market's broad middle; varies more than any category

Two structural facts about this map matter more than any row. First, consolidation keeps redrawing it: three of the named companies changed hands or absorbed a competitor since mid-2024, and Radiology Partners agreed to acquire Everlight Radiology in August 2026 at a reported value near 1 billion dollars. A company's category can change mid-contract, which is a contracting problem before it is a shopping problem. Second, publication habits differ by category more than performance claims do: across the largest companies, almost none publishes a price, a turnaround measurement method, or a compliance percentage, a gap documented vendor by vendor in the 2026 companies comparison, which audits what each of the big names does and does not put on its own site.

Why not just rank the teleradiology companies?

Because the honest ranking function takes your inputs, and a listicle does not have them. A hospital emergency department hiring overnight depth should weight measured STAT turnaround and escalation behavior; an outpatient imaging center with a cross-sectional elective mix should weight subspecialty routing and prior comparison; an urgent care network should weight plain-film unit economics and same-day finals. Run those three weightings over the same six companies and you get three different orderings, all correct. This is also why competitor-written top-ten lists agree with each other so poorly.

There is a second, quieter reason: the data a ranking would need is mostly unpublished. When the largest companies in the market publish no price and no measured turnaround, a ranking claiming precision is interpolating from marketing copy. The framework below is built for that reality; it converts each unpublished claim into a document request, and a company's willingness to answer becomes evaluation data in itself.

The seven criteria that separate teleradiology companies

1. The product. Preliminary or final reads, per service line, in contract language. This single term moves cost, morning workflow, and liability, and companies sell both under identical labels; STAT vs preliminary vs final reads is the decoder. Document to request: the service line definitions page of the draft agreement.

2. Turnaround, with its clock. The tier ceilings, what event starts and stops the clock, and the compliance percentage over a trailing period. Last-image arrival to radiologist signature is the buyer-protective definition. Document: the SLA with definitions, plus a sample monthly report. AstraRad's version is public on the SLA page: STAT under 1 hour, 30 minute measured median, 99.4 percent trailing compliance.

3. Subspecialty routing. The rule that assigns a study to a reader, and whether subspecialty match is default or upsold. Document: the routing rules from the operational documentation, and the roster by subspecialty section.

4. Licensing and credentialing. Active licenses in your state per assigned reader, verifiable against the state board, and for hospitals a credentialing-by-proxy agreement meeting 42 CFR 482.22. Document: the license roster and the delegation agreement. The verification guide covers the lookups.

5. The quality program. Peer review sampling rate, whether the second read is blind, the major discrepancy rate, and who receives the monthly report. The American College of Radiology's teleradiology guidance sets the floor: formal peer review, no ghost reading, interpretation with priors and clinical context. Document: the QA methodology and a redacted sample quality report. A company that publishes an imperfect number, the way AstraRad publishes major discrepancies under 0.3 percent with 1 in 20 reports blind double-read, is making a checkable promise; a company that claims zero is describing its measurement, not its performance.

6. Pricing structure. Every study type priced on one page, the priority multiplier, and every recurring fee: minimums, platform charges, after-hours surcharges, subspecialty upcharges. Market context sits in teleradiology cost per read, and the fee taxonomy in teleradiology hidden fees. Document: the complete written rate card. Refusing to publish prices is market-normal; refusing to write them down for you is not.

7. Ownership and stability. Who owns the company, what changed hands recently, and what the contract says happens on the next change of control. Document: the assignment and change-of-control clauses, plus five minutes with the state corporate registry. Consolidation is the market's weather now, and the alternatives-shopping pattern that follows each acquisition shows how many buyers skip this criterion until it is expensive.

How should different facilities weight the criteria?

The criteria are constant; the weights are not. A defensible starting matrix, which your own failure mode should adjust:

Criterion	Hospital ED and inpatient	Outpatient imaging center	Urgent care network	Radiology group buying cover
Product (finals)	High	High	High	Highest; prelims recreate the morning re-read
Turnaround and clock	Highest	Medium	High	Medium
Subspecialty routing	Medium	Highest	Low for plain films	High
Licensing and credentialing	High	Medium	Medium	Medium
Quality program	High	High	Medium	Highest; the committee will ask
Pricing structure	Medium	High	Highest; volume is variable	Medium
Ownership stability	Medium	Medium	Low	High; the vendor may bid against you

The one cell buyers most often misweight is urgent care subspecialty routing: on wrist and chest X-rays the subspecialty premium buys little, and paying it across a plain-film-heavy mix is real money. The correction runs the other way at imaging centers, where a generalist read on advanced MRI surfaces as addendum rates and referrer complaints months after the price looked good. Match the weight to the study mix, and re-run the exercise when the mix changes; the fuller checklist version of this process is in how to choose a teleradiology company.

Red flags that end an evaluation early

Some findings should remove a company from the shortlist outright instead of costing it points, because each one predicts a specific operational failure you will meet later.

A number that will not go in the contract. The marketing page says 30-minute turnaround; the draft agreement says commercially reasonable efforts. The delta between the two documents is the company's own estimate of its performance, and it is the most reliable signal in the entire evaluation.

A clock with no definition. Turnaround quoted with no start and stop events is unpriceable. If the definition finally produced starts the clock at "study assigned," the queue time you will actually experience has been defined out of the number.

Licensure answered at the network level. "Our radiologists are licensed in all 50 states" is a statement about the network, and your studies are read by the roster on your account. The answerable version is a named list you can check against your state board in an afternoon.

A quality program with no output. Peer review described as a process, with no sampling rate, no discrepancy figure, and no client-facing report. A program whose results never leave the company is unauditable by construction, and a claimed discrepancy rate of zero is worse: it measures the measurement.

The vanishing fee schedule. A per-study rate quoted enthusiastically while platform fees, minimums, after-hours surcharges, and interface charges surface one at a time across the negotiation. Companies that price transparently hand over the whole schedule at once; the drip pattern is itself the disclosure.

Roster churn your credentialing office discovers. Ask how many readers joined and left client accounts in the past year. High churn shows up later as a permanent credentialing backlog for hospitals and as inconsistent report style for everyone.

None of these flags is about size or category; nationals and boutiques exhibit and avoid them in equal measure. They are about whether the company's operational reality can survive contact with its own paperwork.

How pricing structure tracks company category

Structure varies by category more predictably than rates do, which makes it a useful cross-check on the map above. National networks tend toward committed-volume contracts with platform and interface fees, built for health-system procurement where a minimum is easy to clear. Large independents mix models by client size. Platform practices frequently carry technology charges reflecting their in-house PACS investment. Subspecialty final-read practices, AstraRad among them, tend to price per signed report because their buyers' volumes are variable, and the cleanest versions attach no recurring fees at all: per-report vs subscription structures compares the arithmetic.

The cross-check works in both directions. A self-described boutique quoting a national-style contract, minimums, platform fee, multi-year term, is telling you what it is becoming, and possibly who now owns it. A slow month is where the structures separate: under a minimum, 750 studies against a 1,000-study commitment still bills for 1,000, which lifts the effective per-study price by a third; under per-report billing the slow month simply invoices fewer reports. Model your own worst quarter under each shortlisted company's structure before scoring criterion six, and treat any structure you cannot model from the documents provided as unpriced.

Running the evaluation in two weeks

The framework compresses to a schedule a busy imaging director can actually run. Days 1 to 3: type yourself with the weighting table, shortlist two or three companies of the matching category. Days 4 to 8: send each the seven document requests above; what returns complete and fast is data, and what returns as a call request instead of a document is data too. Days 9 to 12: verify licenses and certifications against public sources, call one reference per company with narrow questions. Days 13 and 14: score, then start a paid pilot with the leader rather than a contract, twenty representative studies through the full loop with your medical director reading the output.

Per-report pricing makes the pilot cheap at any company that offers it, and the pilot is where marketing and operations finally have to match. AstraRad's terms for exactly this process: a complete written rate card within one business day of a request, no minimums so the pilot costs twenty reports, and the pricing model printed in full before you commit to anything.